|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 8.340 USD | +2.58% |
|
+4.77% | +24.70% |
| 08-11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.58% | +4.77% | +3.99% | +35.61% | +24.70% | +85.75% | -80.60% | -87.55% | -68.17% | 37.97M | |
| +0.35% | -2.99% | +6.68% | +25.10% | +13.00% | +20.52% | +30.32% | +15.08% | +315.56% | 242B | |
| +1.09% | -4.65% | +3.08% | +8.15% | -6.49% | -0.43% | -0.93% | -28.30% | +175.64% | 150B | |
| -2.32% | -3.27% | +6.89% | -8.00% | -30.79% | -13.35% | +35.02% | +21.16% | +392.25% | 138B | |
| -1.46% | -3.01% | -10.88% | -5.63% | -55.32% | -56.23% | -17.36% | +0.45% | +82.99% | 61.74B | |
| -0.05% | -1.32% | -5.28% | -9.77% | -0.12% | +10.48% | +19.48% | -19.95% | +114.36% | 49.08B | |
| +0.66% | +0.19% | -2.92% | +8.26% | -15.72% | -20.53% | -21.81% | -31.34% | - | 47.43B | |
| +0.66% | -2.90% | +11.22% | +28.38% | +23.30% | +18.46% | +50.25% | +10.12% | +258.27% | 47.3B | |
| -3.05% | -2.62% | -0.64% | +41.81% | +22.44% | -7.75% | +36.34% | -2.23% | +578.07% | 44.25B | |
| -0.08% | -1.92% | +3.87% | +12.11% | +11.95% | +29.48% | +58.80% | +22.35% | +168.78% | 41.78B | |
| +2.75% | +1.13% | +25.12% | +44.71% | +108.17% | +167.37% | +97.40% | -28.12% | +50.67% | 41.23B | |
| -1.02% | -1.40% | -4.14% | +4.42% | -9.13% | -21.43% | +47.89% | -14.17% | +241.38% | 30.78B | |
| +1.45% | +4.85% | -5.06% | +15.21% | -15.30% | -34.34% | -40.21% | -58.14% | - | 29.1B | |
| +0.48% | -3.51% | -6.64% | -1.94% | -21.62% | -16.03% | -5.29% | - | - | 29.04B | |
| +0.33% | -2.74% | -4.83% | -13.85% | -8.48% | -10.89% | +18.49% | -38.28% | -11.48% | 23.4B | |
| +0.16% | -2.67% | +5.99% | +10.94% | +1.70% | +9.78% | -19.99% | -50.76% | +235.83% | 17.65B | |
| +1.66% | +0.28% | +16.36% | +33.20% | +56.62% | +61.12% | +41.04% | -11.43% | +171.71% | 16.91B | |
| -0.31% | -3.37% | -3.22% | +10.66% | -1.64% | +0.36% | +1.19% | -16.42% | +111.03% | 13.19B | |
| +2.16% | +4.84% | -1.11% | +2.33% | -14.45% | -29.22% | +3.15% | - | - | 13.09B | |
| +2.85% | -0.94% | -4.55% | -24.72% | -27.14% | -47.10% | +93.89% | +210.50% | +2,804.87% | 11.35B | |
| Average | +0.45% | -1.20% | +1.70% | +10.85% | +2.79% | +7.30% | +17.35% | -5.95% | +351.36% | 52.42B | |
| Weighted average by Cap. | -0.01% | -2.44% | +3.20% | +11.59% | -0.27% | +5.44% | +22.32% | -1.89% | +282.18% |
- Stock Market
- Stocks
- HBIO Stock
- Sector Harvard Bioscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
